{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:41:52Z","timestamp":1776181312931,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jad.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T08:04:49Z","timestamp":1607414689000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-2843","authenticated-orcid":false,"given":"Jun","family":"Ishigooka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-3434","authenticated-orcid":false,"given":"Mari","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Hagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.12.005_bib0001","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12888-016-1143-8","article-title":". Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder","volume":"16","author":"Bai","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0002","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4088\/JCP.v65n1109","article-title":"Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a US community based sample","volume":"65","author":"Calabrese","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0003","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/appi.ajp.2012.12010123","article-title":"Initial validity and reliability data on the Columbia-Suicide Severity Rating Scale","volume":"169","author":"Chappell","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0004","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4088\/JCP.v67n0514","article-title":". A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression","volume":"67","author":"Corya","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0005","doi-asserted-by":"crossref","first-page":"18m02366","DOI":"10.4088\/PCC.18m02366","article-title":". Metabolic syndrome in Dutch patients with bipolar disorder: A cross-sectional study","volume":"20","author":"de Jong","year":"2018","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jad.2020.12.005_bib0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1185\/030079903125002801","article-title":"A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder","volume":"20","author":"Dean","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2020.12.005_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-0179-5-3","article-title":"A systematic review of the evidence of the burden of bipolar disorder in Europe","volume":"5","author":"Fajutrao","year":"2009","journal-title":"Clin. Pract. Epidemiol. Mental Health"},{"key":"10.1016\/j.jad.2020.12.005_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jad.2015.02.011","article-title":"Long-term morbidity in bipolar-I, bipolar-II, and major depressive disorders","volume":"178","author":"Forte","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.12.005_bib0009","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4088\/JCP.v67n0806","article-title":"The economic impact of bipolar disorder in an employed population from an employer perspective","volume":"67","author":"Gardner","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jad.2020.12.005_bib0011","first-page":"39","article-title":"Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol","volume":"18","author":"Inada","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.12.005_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":". Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2020.12.005_bib0013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":". The long term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0014","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12888-019-2181-9","article-title":". Long-term mood\/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression","volume":"19","author":"Kanba","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.13137","article-title":". Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression","author":"Kato","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2020.12.005_bib0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/da.22479","article-title":"Lurasidone in the long-term treatment of patients with bipolar disorder: a 24-week open-label extension study","volume":"33","author":"Ketter","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2020.12.005_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2017.07.023","article-title":"Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials","volume":"223","author":"Liu","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.12.005_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":". Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0019","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":". Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":". Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0021","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl 20","key":"10.1016\/j.jad.2020.12.005_bib0022","first-page":"22","article-title":". The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSMIV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0023","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.jad.2020.12.005_bib0024","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jad.2020.12.005_bib0026","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":". Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.12.005_bib0027","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":". Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2020.12.005_bib0028","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.jad.2021.09.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000}},{"DOI":"10.1016\/j.jad.2021.06.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000}}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720330895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720330895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T13:19:43Z","timestamp":1668604783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720330895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"alternative-id":["S0165032720330895"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.12.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jad.2021.06.004","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.jad.2021.09.012","asserted-by":"object"}]},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}